Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD

    2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    Start listeningView podcast show

    2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD

    FromKnow Diabetes by Heart™ Professional Education Podcast Series

    ratings:
    Length:
    29 minutes
    Released:
    Oct 20, 2020
    Format:
    Podcast episode

    Description

    Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
    Released:
    Oct 20, 2020
    Format:
    Podcast episode

    Titles in the series (33)

    The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The American Heart Association’s and the American Diabetes Association's Know Diabetes by Heart Professional Education™ Podcast Series is brought to you by founding sponsors, Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsors, Sanofi, AstraZeneca, and Bayer.